TREATMENT OF NEUROLEPTIC MALIGNANT SYNDROME WITH DANTROLENE

Neuroleptic Malignant syndrome caused by dopamine‐depleting drugs in a patient with Huntington disease

Robert E. Burke, Stanley Fahn, Richard Mayeux et al. · Neurology · 1981 · 171 citations

Medicine, Neurology, Pharmacology +10

Effects of mode of management on plasma chlorpromazine in psychiatric patients

Leonor Rivera‐Calimlim, Lina Paola Villamil Castañeda, Louis Lasagna · Clinical Pharmacology & Therapeutics · 1973 · 148 citations

Medicine, Pharmacology, Psychiatry +17

Malignant Neuroleptic Syndrome—Its Present Status in Japan and Clinical Problems

Hitoshi Itoh, Nobuo Ohtsuka, Kazuhiro Ogita et al. · Psychiatry and Clinical Neurosciences · 1977 · 100 citations

Medicine, Neurology, Psychiatry +13

Neuroleptic malignant syndrome

Victor W. Henderson, G. Frederick Wooten · Neurology · 1981 · 71 citations

DANTROLENE AND THE TREATMENT OF MALIGNANT HYPERTHERMIA

G. M. Hall · British Journal of Anaesthesia · 1980 · 19 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +5